Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinz Drexel

Showing results (1-10 of 278) with videos related to

Pageof 28
Sort By:
Fundamental & Clinical Pharmacology|November 16, 2007
Nicotinic acid in the treatment of hyperlipidaemiaHeinz Drexel
European Heart Journal. Cardiovascular Pharmacotherapy|April 1, 2017
A commentary on the new ESC guidelines on dyslipidaemiasHeinz Drexel
European Heart Journal. Cardiovascular Pharmacotherapy|January 10, 2018
Cost-effectiveness with PCSK9 inhibitors: a matter of costsHeinz Drexel
Fundamental & Clinical Pharmacology|August 18, 2009
Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?Heinz Drexel
European Heart Journal|January 14, 2022
PCSK9 inhibition in patients with heart failure: neutral or harmful intervention?Alexander Niessner, Heinz Drexel
Wiener Medizinische Wochenschrift (1946)|December 19, 2003
[Diabetes and lipids]Monika Lechleitner, Heinz Drexel
European Heart Journal. Cardiovascular Pharmacotherapy|January 14, 2020
ESC Guidelines revisitedHeinz Drexel, Stephan Milbradt
Cardiology|November 21, 2023
Bempedoic Acid: How Will It Shape the Future Lipid-Lowering Landscape? Mode of Action, Evidence, and Clinical UseHeinz Drexel, Arthur Mader
Atherosclerosis|April 30, 2024
Subclinical atherosclerosis: More data - More insights into preventionHeinz Drexel, Andreas Festa
Atherosclerosis|November 7, 2024
Reply to: "Correspondence on: "Subclinical atherosclerosis: More data - More insights into prevention" "Heinz Drexel, Andreas Festa
Pageof 28

Showing results (1-10 of 278) with videos related to

Sort By:
Pageof 28
Fundamental & Clinical Pharmacology|November 16, 2007
Nicotinic acid in the treatment of hyperlipidaemiaHeinz Drexel
European Heart Journal. Cardiovascular Pharmacotherapy|April 1, 2017
A commentary on the new ESC guidelines on dyslipidaemiasHeinz Drexel
European Heart Journal. Cardiovascular Pharmacotherapy|January 10, 2018
Cost-effectiveness with PCSK9 inhibitors: a matter of costsHeinz Drexel
Fundamental & Clinical Pharmacology|August 18, 2009
Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?Heinz Drexel
European Heart Journal|January 14, 2022
PCSK9 inhibition in patients with heart failure: neutral or harmful intervention?Alexander Niessner, Heinz Drexel
Wiener Medizinische Wochenschrift (1946)|December 19, 2003
[Diabetes and lipids]Monika Lechleitner, Heinz Drexel
European Heart Journal. Cardiovascular Pharmacotherapy|January 14, 2020
ESC Guidelines revisitedHeinz Drexel, Stephan Milbradt
Cardiology|November 21, 2023
Bempedoic Acid: How Will It Shape the Future Lipid-Lowering Landscape? Mode of Action, Evidence, and Clinical UseHeinz Drexel, Arthur Mader
Atherosclerosis|April 30, 2024
Subclinical atherosclerosis: More data - More insights into preventionHeinz Drexel, Andreas Festa
Atherosclerosis|November 7, 2024
Reply to: "Correspondence on: "Subclinical atherosclerosis: More data - More insights into prevention" "Heinz Drexel, Andreas Festa
Pageof 28